Lung cancer now kills more women than breast cancer

Megan Applegate | | Health Imaging | Oncology Imaging

Lung cancer has now surpassed breast cancer as the leading cause of cancer death among women.

A new report from the America Cancer Society states that lingering effects from the tobacco epidemic are partly to blame and women in developed countries are the hardest hit.

The study used data from 2012 and reported that lung cancer killed 209,000 women in developed countries in 2012, while 197,000 women died of breast cancer.

Read more on this development from Time at the link below: 

Lung Cancer Now Kills More Women Than Breast Cancer in Developed Countries

Megan Applegate

Related Content

Imaging may be misleading when determining the success of cancer treatment
Prostate cancer radiotherapy timeline can be safely shortened
New radiopharmaceutical targeted at gastrointenstinal cancers yields impressive results
New PET method combines antibody with radioactive isotope to improve lung cancer detection
VI-RADS threshold, imaging features predict bladder cancer invasiveness with nearly 100% accuracy
PHOTO GALLERY: thyroid nodule imaging

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.